Abiopharma

(30% Negative) N-ABLE, INC. (NABL) Reports Q2 2026 Financial Results

(30% Negative) BKV CORP (BKV) Reports Q2 2026 Financial Results

(70% Positive) SHIFT4 PAYMENTS, INC. (FOUR) Reports Q2 2026 Financial Results

(99% Positive) MIDDLEBY CORP (MIDD) Reports Q2 2026 Financial Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Directors Interest

New Form DFAN14A - BNY MELLON STRATEGIC MUNICIPALS, INC. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0000902664-26-002300 <b>Size:</b> 5 MB

(99% Positive) PAGAYA TECHNOLOGIES LTD. (PGYWW) Reports Q2 2026 Financial Results

(10% Negative) NEWAMSTERDAM PHARMA CO N.V. (NAMSW) Reports Q2 2026 Financial Results

Evolent Announces First Quarter 2026 Results

Pagaya Appoints Chief Strategy Officer Jonathan Dobres as CFO, Succeeding Evangelos Perros

FHLBank Chicago and Associated Bank Award $375,000 to Support Emerging Housing Developers

(80% Positive) FOGHORN THERAPEUTICS INC. (FHTX) Announces Enrollment Update for escalation Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(100% Positive) CUSHMAN & WAKEFIELD LTD. (CWK) Reports Q2 2026 Financial Results

(10% Negative) INSMED INC (INSM) Reports Q2 2026 Financial Results

enGene Announces Updated Interim Results From LEGEND Pivotal Cohort